Symbiotec Pharmalab’s Initial Public Offer of Rs17,570 million: Price Band is fixed at Rs938-Rs988 per Equity Share of face value of Rs2 each
FinTech BizNews Service
Mumbai, 19 August, 2026: Symbiotec Pharmalab Limited proposes to open the Bid / Offer Period in relation to its Initial Public Offer of the Equity Shares on Monday, August 24, 2026.
The Offer comprises a fresh issue of such number of Equity Shares by the Company aggregating up to Rs1,500.00 million (“Fresh Issue”) and offer for sale of up to Rs16,070.00 million (“Offer for Sale”) by certain existing shareholders of the Company (the “Selling Shareholders”) (collectively, the “Total Offer Size”).
L to R: Ms. Cheryl Netto, JM Financial; Symbiotec Pharmalab Limited management team-Shubham Saboo, Gm, CMD Office; Raghavender Ramachandran, CFO ; Anil Satwani, Chairman And Managing Director; Kapil Mishra, Head-Strategy, CMD Office; Mrs Kashish Satwani (Promoter) ; Krishna Satwani, Head Bd Injectable And Mahesh Natarajan, Nomura Financial Advisory And Securities (India)
The Company proposes to utilise the Net Proceeds towards Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company; and General corporate purposes. (the “Objects of the Offer”)
The Offer for Sale comprises of such number of Equity Shares aggregating up to Rs1,440.00 million by Satwani Holdings LLP (the “Promoter Selling Shareholder”), of such number of Equity Shares aggregating up to Rs9,880.00 million by Rosewood Investments, and of such number of Equity Shares aggregating up to Rs4,750.00 million by India Business Excellence Fund – III (collectively, the “Investor Selling Shareholders”).
The Anchor Investor Bid/Offer Period opens and closes on Friday, August 21, 2026. The Bid/Offer Period will open on Monday, August 24, 2026, for subscription and close on Thursday, August 27, 2026. ( “Bid/Offer Period”).
The Price Band of the Offer has been fixed at Rs938 to Rs988 per Equity Share (the “Price Band”). Bids can be made for a minimum of 15 Equity Shares and in multiples of 15 Equity Shares thereafter (the “Bid Lot”). Discount Of Rs 90.00 Per Equity Share of Face Value of Rs2 is being offered to Eligible Employees Bidding in the Employee Reservation Portion
This Equity Shares are being offered through the Red Herring Prospectus of the Company dated August 18, 2026 filed with the Registrar of Companies at Madhya Pradesh at Gwalior ( “RoC”).
The Equity Shares to be offered through the Red Herring Prospectus are proposed to be listed on the stock exchanges being BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE” together with BSE, the “Stock Exchanges”). For the purposes of the Offer, BSE Limited is the Designated Stock Exchange. (The “Listing Details”)
JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited are the book running lead managers to the Offer (“Book Running Lead Managers “or “BRLMs”).
